| Name | Title | Contact Details |
|---|
CASI Pharmaceuticals, Inc. (NASDAQ:CASI) is a biopharmaceutical company dedicated to the acquisition, development and commercialization of innovative therapeutics addressing cancer and other unmet medical needs for the global market with a primary focus on China. Our mission is to become an integrated biopharmaceutical company with significant market share in China, while establishing partnerships for global development and commercialization. Part of our strategy is to leverage our expertise and resources in North America and China to bring safer, more effective, and/or easier-to-use drugs to patients and to develop them more cost-effectively and faster using our unique dual development approach.
Anhydro A/S is a Elkridge, MD-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Fitness Enterprises d/b/a First In Fitness is a Barre, VT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
MSP Corporation is one of the leading companies in the Healthcare, Pharmaceuticals, and Biotech sector.
Active Ice Inc is a Norman, OK-based company in the Healthcare, Pharmaceuticals, and Biotech sector.